Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study.
Van Tassell B, Mihalick V, Thomas G, Marawan A, Talasaz AH, Lu J, Kang L, Ladd A, Damonte JI, Dixon DL, Markley R, Turlington J, Federmann E, Del Buono MG, Biondi-Zoccai G, Canada JM, Arena R, Abbate A.
Van Tassell B, et al. Among authors: abbate a.
J Transl Med. 2022 Jun 15;20(1):270. doi: 10.1186/s12967-022-03466-9.
J Transl Med. 2022.
PMID: 35706006
Free PMC article.
Clinical Trial.